Schizophrenia: open trials in China

55 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07652866
Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia
Trial Treatment · Second Xiangya Hospital of Central South University
Xiangya Second Hospital, Changsha
Registry updated 2026-06-18
NCT06904092
Efficacy and Mechanisms of TUS on Cognitive Deficits in Schizophrenia: Based on the Hippocampal-Prefrontal Circuit
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-06-12
NCT05159349
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
Research · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-06-08
NCT07604129
Transcranial Sonography and Machine Learning for Schizophrenia Identification
Research · Taizhou Second People's Hospital
Taizhou Second People's Hospital, Taizhou
Registry updated 2026-05-22
NCT07557368
Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-05-11
NCT07557381
The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-05-11
NCT07479758
Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
Second Affiliated Hospital, School of Medicine, Zhejiang, Hangzhou
Registry updated 2026-04-28
NCT07521683
A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia
Trial Treatment · Phase 2 · NeuShen Therapeutics
NeuShen, Shanghai
Registry updated 2026-04-13
NCT07493551
A Bioequivalence Study of PP3M in Patients With Schizophrenia
Trial Treatment · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Beijing Anding Hospital, Capital Medical University, Beijing
Registry updated 2026-03-25
NCT06580860
Psychiatric Multi-omics and Neuroimaging Project
Research · mingjun Zhong
The Second Xiangya hospital of central south univerity, Changsha
Registry updated 2026-03-13
NCT07444463
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
Trial Treatment · Central South University
Second Xiangya Hospital, Changsha
Registry updated 2026-03-04
NCT06470516
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Trial Treatment · Sir Run Run Shaw Hospital
Sir Run Run Shaw Hospital, Hanzhou · Quzhou Third Hospital, Quzhou
Registry updated 2026-03-02
NCT07396870
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
Trial Treatment · Phase 2 · Luye Pharma Group Ltd.
Beijing Anding Hospital, Capital Medical University, Beijing
Registry updated 2026-02-09
NCT07162467
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Research · Tianjin Anding Hospital
Tianjin Anding Hospital, Tianjin
Registry updated 2026-01-14
NCT07176468
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
Trial Treatment · Anhui Medical University
Anhui Medical University, Hefei
Registry updated 2025-12-30
NCT06642675
nTMS for Negative Symptom in Schizophrenia
Trial Treatment · Central South University
Mental Health Institute of Second Xiangya Hospital,CSU, Changsha
Registry updated 2025-12-05
NCT07230652
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Trial Treatment · Phase 1 · Luye Pharma Group Ltd.
Beijing Anding Hospital, Capital Medical University, Beijing
Registry updated 2025-11-19
NCT07075237
Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia
Trial Treatment · Phase 4 · Jiangsu Province Nanjing Brain Hospital
Nanjing Brain Hospital, Nanjing
Registry updated 2025-09-29
NCT07139171
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Research · Tianjin Anding Hospital
Tianjin Anding Hospital, Tianjin
Registry updated 2025-09-24
NCT07129369
Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program
Trial Treatment · Chinese University of Hong Kong
Psychiatric outpatient clinics in one hospital cluster of Hospital Authority, Hong Kong · Integrated Community Centers for Mental Wellness, Hong Kong
Registry updated 2025-08-19
NCT06904079
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2025-08-17
NCT07074704
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
Trial Treatment · Tongji University
Shanghai Pudong New Area Mental Health Center, Shanghai
Registry updated 2025-07-24
NCT05866107
App and Body Fat Scale in the Management of Overweight Patients
Trial Treatment · Capital Medical University
Beijing Anding Hospital, Beijing
Registry updated 2025-06-05
NCT06888726
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2025-06-04
NCT06542640
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis
Trial Treatment · Beth Israel Deaconess Medical Center
Shanghai Mental Health Center, Shanghai
Registry updated 2025-04-20

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error